US2008081062A1PendingUtilityA1

Medical apparatus and method for producing same

Assignee: NIPPON SHERWOOD MED IND LTDPriority: Oct 3, 2006Filed: Oct 1, 2007Published: Apr 3, 2008
Est. expiryOct 3, 2026(~0.2 yrs left)· nominal 20-yr term from priority
A61L 29/06A61P 31/00A61L 29/16A61L 2300/406A61P 31/04
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A medical device that includes at least one antibiotic in a macromolecular substance that swells upon contact with a solvent. Also, a method for preparing an antibiotic-containing medical device that involves contacting a medical device having at least a portion of the surface formed from a swellable macromolecular substance, with a solvent that swells the macromolecular substance, contacting the swollen macromolecular substance with at least one antibiotic, and removing the solvent from the swollen macromolecular substance.

Claims

exact text as granted — not AI-modified
1 . A method for preparing an antibiotic-containing medical device comprising:
 (a) providing a medical device having at least a portion of the surface formed from a swellable macromolecular substance,   (b) contacting the medical device with a solvent that swells the macromolecular substance)   (c) contacting the swollen macromolecular substance with at least one antibiotic, and   (d) removing the solvent from the swollen macromolecular substrate.   
     
     
         2 . The method of  claim 1  wherein the medical device comprises a synthetic resin. 
     
     
         3 . The method of  claim 2  wherein the synthetic resin is selected from the group consisting of a polyurethane, a polyamide, and combinations thereof. 
     
     
         4 . The method of  claim 1  wherein the solvent comprises an aprotic polar solvent. 
     
     
         5 . The method of  claim 4  wherein the aprotic polar solvent is selected from the group consisting of dimethylformamide, dimethyl sulphoxide, dimethylacetamide, 2-butanone, acetone, acetinitrile, N-methylpyrrolidone, and combinations thereof. 
     
     
         6 . The method of  claim 1  wherein the antibiotic is a water soluble antibiotic. 
     
     
         7 . The method of  claim 6  wherein the water soluble antibiotic is selected from the group consisting of isepamicin sulphate, amikacin sulphate, tobramycin, kitasamycin tartrate, and combinations thereof. 
     
     
         8 . The method of  claim 1 , wherein the antibiotic is retained within the macromolecular substance. 
     
     
         9 . The method of  claim 1 , wherein at least a portion of the macromolecular substance comprises a meshwork structure, and the antibiotic is retained in said meshwork structure. 
     
     
         10 . The method of  claim 1  wherein the solvent is removed from the swollen macromolecular substance by a method selected from the group consisting of drying, washing, and combinations thereof. 
     
     
         11 . A medical device produced by the method of  claim 1 . 
     
     
         12 . A medical device comprising a synthetic resin comprising a macromolecular substance that swells upon contact with a solvent, and that has at least one antibiotic in the macromolecular substance. 
     
     
         13 . The medical device of  claim 12  wherein the synthetic resin is selected from the group consisting of a polyurethane, a polyamide, and combinations thereof. 
     
     
         14 . The medical device of  claim 12  wherein the antibiotic is a water soluble antibiotic. 
     
     
         15 . The medical device of  claim 14  wherein the water soluble antibiotic is selected from the group consisting of isepamicin sulphate, amikacin sulphate, tobramycin, kitasamycin tartrate, and combinations thereof. 
     
     
         16 . The medical device of  claim 12  wherein the solvent is an aprotic polar solvent. 
     
     
         17 . The medical device of  claim 12  wherein the medical device is selected from the group consisting of a catheter and a tube. 
     
     
         18 . The medical device of  claim 12  wherein at least a portion of the macromolecular substance comprises a meshwork structure and the antibiotic is retained in said meshwork structure. 
     
     
         19 . The medical device of  claim 18  wherein the antibiotic is a water soluble antibiotic. 
     
     
         20 . The medical device of  claim 18  wherein the solvent is an aprotic polar solvent. 
     
     
         21 . The medical device of  claim 18  wherein the medical device is selected from the group consisting of a catheter and a tube.

Join the waitlist — get patent alerts

Track US2008081062A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.